Demonstrates a significant difference between ME / CFS patients and healthy controls.
Julie Wilhelmy
Ronald W. Davis, PhD
Coming soon…
TECHNOLOGY DESCRIPTION
Developed by Julie Wilhelmy in collaboration with Ronald W. Davis, PhD, at Stanford University.
The Seahorse instrument measures oxygen during energy production processes that occur in the mitochondria. A protocol using the Seahorse has revealed a significant difference between activated T-cells of ME / CFS patients and healthy controls.
The instrument is commercially available, which will allow other laboratories to easily reproduce the results.
TECHNOLOGY DESCRIPTION
Developed by Julie Wilhelmy, PhD, in collaboration with Ronald W. Davis, PhD, at Stanford University.
The Seahorse instrument measures oxygen during energy production processes that occur in the mitochondria. A protocol using the Seahorse has revealed a significant difference between activated T-cells of ME/CFS patients and healthy controls.
The instrument is commercially available, which will allow other laboratories to easily reproduce the results.
Open Medicine Foundation®
29302 Laro Drive, Agoura Hills, CA 91301 USA
Phone: 650-242-8669